|
|
Article: Optimer Pharmaceuticals Announces Publication in Peer-Reviewed Journal about Prulifloxacin's Antibacterial Activity against Infectious Diarrhea Producing Bacteria.
- Article from:
- Women's Health Weekly
- Article date:
- March 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced the publication of in vitro data highlighting the antibacterial activity of prulifloxacin in the March 2009 edition of Antimicrobial Agents and Chemotherapy published by the American Society for Microbiology. The article is titled, oAntimicrobial Activity of Prulifloxacin Tested against a Worldwide Collection of Gastroenteritis-Producing Pathogens, Including Those Causing TravelerEs Diarrheao (AAC March 2009; v.53: 1221-1224). The results from these studies compared the in vitro antibacterial activity of prulifloxacin to that of other antimicrobial agents against 582 strains from global surveillance studies, including ...
Related newspaper, magazine, and journal articles:
|
|
Article: Optimer Pharmaceuticals to Present at October 2009 ...
PR Newswire;
September 28, 2009 ;
597 words
... ... the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical ... diarrhea, a form of infectious diarrhea. Additional information ... com/. Contacts Optimer Pharmaceuticals, Inc. Christina Donaghy ...
|
|